- Report
- May 2025
- 182 Pages
Global
From €3175EUR$3,545USD£2,707GBP
€3528EUR$3,939USD£3,008GBP
- Report
- June 2025
- 576 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- July 2024
- 96 Pages
Global
From €3500EUR$4,186USD£3,088GBP
- Report
- April 2025
- 200 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- February 2024
- 117 Pages
Global
From €4255EUR$4,750USD£3,627GBP
- Report
- January 2023
- 116 Pages
Global
From €4031EUR$4,500USD£3,436GBP
- Report
- July 2024
- 94 Pages
Global
From €3500EUR$4,186USD£3,088GBP
The GI Stool Test market within the context of In Vitro Diagnostics is a segment of the medical diagnostics industry that focuses on the detection of gastrointestinal diseases and disorders. It is a rapidly growing market, driven by the increasing prevalence of gastrointestinal diseases and the need for early diagnosis and treatment. GI Stool Tests are used to detect a variety of gastrointestinal conditions, including bacterial infections, parasites, and inflammatory bowel disease. These tests are typically performed in a laboratory setting and can provide valuable information to healthcare providers.
The GI Stool Test market is highly competitive, with a number of companies offering a range of products and services. Some of the major players in the market include Quest Diagnostics, LabCorp, Bio-Rad Laboratories, and Genova Diagnostics. Other companies in the market include Eurofins Scientific, Mayo Medical Laboratories, and ARUP Laboratories. Show Less Read more